检索结果 - Thomas Manley
- Showing 1 - 16 results of 16
-
1
-
2
-
3
-
4
Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. 由 Michael A. Caligiuri, Antanina Zmuidzinas, Thomas Manley, Herbert Levine, Kendall A. Smith, Jerome Ritz
出版 1990Artigo -
5
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epito... 由 Matthias Wölfl, Jürgen Kuball, William Ho, Hieu Nguyen, Thomas Manley, Marie Bleakley, Philip D. Greenberg
出版 2007Artigo -
6
-
7
Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit 由 Jonathan A. Gutman, Cameron J. Turtle, Thomas Manley, Shelly Heimfeld, Irwin D. Bernstein, Stanley R. Riddell, Colleen Delaney
出版 2009Artigo -
8
Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. 由 M. J. Robertson, RJ Soiffer, S F Wolf, Thomas Manley, Christine P. Donahue, Deborah Young, S H Herrmann, Jerome Ritz
出版 1992Artigo -
9
-
10
Brentuximab vedotin, an antibody–drug conjugate, in patients with CD30‐positive haematologic malignancies and hepatic or renal impairment 由 Baiteng Zhao, Robert Chen, Owen A. O’Connor, Ajay K. Gopal, Radhakrishnan Ramchandren, André Goy, Jeffrey Matous, Adedigbo A. Fasanmade, Thomas Manley, Tae Hyung Han
出版 2016Artigo -
11
Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis 由 Stuart M. Sprague, Ezequiel Bellorín-Font, Vanda Jorgetti, Aluízio Barbosa Carvalho, Hartmut H. Malluche, Aníbal Ferreira, Patrick C. D’Haese, Tilman B. Drüeke, Hongyan Du, Thomas Manley, Eudocia Rojas, Sharon M. Moe
出版 2015Artigo -
12
Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study 由 Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M. Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A. Johnson, Neha Mehta–Shah, Thomas Manley, Stephen Francis, Manish Sharma, Alison J. Moskowitz
出版 2019Artigo -
13
Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma 由 Radhakrishnan Ramchandren, Ranjana H. Advani, Stephen M. Ansell, Nancy L. Bartlett, Robert Chen, Joseph M. Connors, Tatyana Feldman, Andres Forero‐Torres, Jonathan W. Friedberg, Ajay K. Gopal, Leo I. Gordon, John Kuruvilla, Kerry J. Savage, Anas Younes, Gerald Engley, Thomas Manley, Keenan Fenton, David J. Straus
出版 2019Artigo -
14
Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection 由 Sudeb C. Dalai, Jennifer N. Dines, Thomas M. Snyder, Rachel Gittelman, Tera Eerkes, Pashmi Vaney, Sally Howard, Kipp Akers, Lynell R. Skewis, Anthony Monteforte, Pamela R Witte, Cristina Wolf, Hans P. Nesse, Megan Herndon, Jia Qadeer, Sarah Q. Duffy, Emily Svejnoha, Caroline Taromino, Ian M. Kaplan, John P. Alsobrook, Thomas Manley, Lance Baldo
出版 2022Artigo -
15
T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity 由 Rebecca Elyanow, Thomas M. Snyder, Sudeb C. Dalai, Rachel M. Gittelman, Jim Boonyaratanakornkit, Anna Wald, Stacy Selke, Mark H. Wener, Chihiro Morishima, Alexander L. Greninger, Michael Gale, Tien-Ying Hsiang, Lichen Jing, Michael R. Holbrook, Ian M. Kaplan, H. Jabran Zahid, Damon May, Jonathan M. Carlson, Lance Baldo, Thomas Manley, Harlan Robins, David M. Koelle
出版 2022Artigo -
16
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial 由 Steven M. Horwitz, Owen A. O’Connor, Barbara Pro, Tim Illidge, Michelle A. Fanale, Ranjana H. Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Franck Morschhauser, Eva Domingo‐Domènech, Giuseppe Rossi, Won Seog Kim, Tatyana Feldman, Anne Lennard, David Belada, Árpád Illés, Kensei Tobinai, Kunihiro Tsukasaki, Su‐Peng Yeh, Andrei R. Shustov, Andreas Hüttmann, Kerry J. Savage, Sam Yuen, Swaminathan P. Iyer, Pier Luigi Zinzani, Zhaowei Hua, Meredith Little, Shangbang Rao, Joseph Woolery, Thomas Manley, Lorenz Trümper, David M. Aboulafia, Ranjana H. Advani, Önder Alpdoğan, Kiyoshi Ando, Luca Arcaini, Luca Baldini, Naresh Bellam, Nancy L. Bartlett, David Belada, Dina Ben Yehuda, Fabio Benedetti, Peter Borchman, Dominique Bordessoule, Pauline Brice, Javier Briones, Dolores Caballero, Angelo Michele Carella, Hung Chang, June Weon Cheong, Seok‐Goo Cho, Ilseung Choi, Sylvain Choquet, Andrei Coliţă, Angela Giovanna Congui, Francesco d’Amore, Nam H. Dang, Kelly Davison, Sophie de Guibert, Peter de Nully Brown, Vincent Delwail, Judit Demeter, Francesco Di Raimondo, Young Rok, Eva Domingo, Michael G. Douvas, Martin Dreyling, Thomas Ernst, Michelle A. Fanale, Keith Fay, Tatyana Feldman, Silvia Ferrero, Ian W. Flinn, Andres Forero‐Torres, Christopher P. Fox, Jonathan W. Friedberg, Noriko Fukuhara, José A. García‐Marco, Jorge Gayoso Cruz, José Codina, Rémy Gressin, Andrew Grigg, Ronit Gurion, Jacob Haaber Christensen, Corinne Haïoun, Roman Hájek, Mathias Hänel, Kiyohiko Hatake, Robert Hensen, Netanel A. Horowitz, Steven M. Horwitz, Andreas Hüttmann, Árpád Illés, Tim Illidge, Kenichi Ishizawa, Miguel Islas‐Ohlmayer, Eric D. Jacobsen, Murali Janakiram, Wojciech Jurczak, Mark Kaminski
出版 2018Artigo
相关主题
Biology
Immunology
Biochemistry
Medicine
Cytotoxic T cell
In vitro
Internal medicine
Immune system
Cell biology
CD8
Molecular biology
Natural killer cell
T cell
Antibody
Antigen
Brentuximab vedotin
Lymphoma
Oncology
CD30
Gastroenterology
Interleukin 12
Interleukin 21
Lymphokine-activated killer cell
Receptor
Virology
Adverse effect
Chemistry
Chemotherapy
Coronavirus disease 2019 (COVID-19)
Cytokine